Monthly Archives: November 2017

Page 4 of 41234

Including heart strokes and attacks.

Antidepressant and anti-anxiety medications associated with increased risk of cardiovascular events and loss of life Women with suspected coronary artery disease who survey taking antidepressant and anti-anxiety medications have an increased threat of cardiovascular events, including heart strokes and attacks, and death in comparison to women not taking these medications, according to researchers in the Uniformed Solutions University of medical Sciences . Their paper, ‘Psychotropic medication make use of and risk of adverse cardiovascular occasions in females with suspected coronary artery disease,’ reports recent results from the Women’s Ischemia Syndrome Evaluation research . The WISE research, sponsored by the National Heart, Lung and Bloodstream Institute of the National Institutes of Health, requires investigators at multiple study sites around the U.S., and was designed to develop options for improved assessment and understanding of coronary artery disease in ladies. Continue reading

Call for universal CAH screening By Kirsty Oswald.

In a connected comment, Bridget Wilcken said that more research is still needed into the disease. ‘It is unexpected that after 30 years of neonatal screening worldwide there is still a need for additional screening data and, importantly, follow-up, so that the benefits of screening could be assessed accurately, and screening efficiency can be maximized.’ She provides: ‘There is little question that screening for the disorder fulfils the fundamental criteria for screening – it really is, after all, a potentially lethal disorder.’ Certified from medwireNews with authorization from Springer Health care Ltd. Continue reading

Page 4 of 41234